Abstract
To investigate the serum levels of hyaluronic acid (HA) in Korean female patients with fibromyalgia (FM) and correlate these levels with variables of disease severity including morning stiffness, we measured HA serum levels in 69 FM patients, 72 rheumatoid arthritis (RA) patients, and 71 healthy controls by enzyme-linked binding protein assay. The serum levels of HA in FM patients did not differ from those in the age-matched controls, whereas HA levels were significantly higher in RA patients than in FM patients and controls (both P < 0.001). With a cut-off value of 75 ng/mL, the prevalence of seropositivity was higher in RA patients (59.7%) than in FM patients (26.1%) or controls (14.1%; both P < 0.001). There were no differences in seropositivity between FM patients and controls, or between FM patients with severe symptoms and those with mild symptoms. The HA levels in FM patients were significantly correlated with age, age at diagnosis, age at symptom development, disease duration, symptom duration, and level of education. There were no correlations between HA levels and morning stiffness, tender point counts and scores, or Fibromyalgia Impact Questionnaire, State–Trait Anxiety Inventory, and Beck Depression Inventory scores. In our patients, the serum HA levels were not increased and did not reflect disease severity. These results suggest that serum HA is not a useful laboratory marker for diagnosis and assessment of FM.
References
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172
Tuncer T, Butun B, Arman M, Akyokus A, Doseyen A (1997) Primary fibromyalgia and allergy. Clin Rheumatol 16:9–12
Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S et al (2007) Fibromyalgia syndrome. J Rheumatol 34:1415–1425
Wolfe F, Michaud K (2004) Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 31:695–700
Smith MM, Ghosh P (1987) The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 7:113–122
Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J et al (1990) Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 33:790–799
Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34:799–807
Engstrom-Laurent A, Hallgren R (1985) Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83–88
Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M (1991) Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 34:815–821
Emlen W, Niebur J, Flanders G, Rutledge J (1996) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. J Rheumatol 23:974–978
Yaron I, Buskila D, Shirazi I, Neumann L, Elkayam O, Paran D et al (1997) Elevated levels of hyaluronic acid in the sera of women with fibromyalgia. J Rheumatol 24:2221–2224
Bliddal H, Moller HJ, Schaadt M, Danneskiold-Samsoe B (2000) Patients with fibromyalgia have normal serum levels of hyaluronic acid. J Rheumatol 27:2658–2659
Werle E, Jakel HP, Muller A, Fischer H, Fiehn W, Eich W (2005) Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome. Clin Lab 51:11–19
Kim YA, Lee SS, Park K (2002) Validation of a Korean version of the Fibromyalgia Impact Questionnaire. J Korean Med Sci 17:220–224
Lee SS, Yoon HJ, Park YW (2006) Antipolymer antibody is not associated with fibromyalgia in Korean female patients. Rheumatol Int 27:73–77
Bjork J, Kleinau S, Tengblad A, Smedegard G (1989) Elevated levels of serum hyaluronate and correlation with disease activity in experimental models of arthritis. Arthritis Rheum 32:306–311
Goldberg RL, Rubin AS (1989) Serum hyaluronate as a marker for disease severity in the Lactobacillus casei model of arthritis in the rat. J Rheumatol 16:92–96
Majeed M, McQueen F, Yeoman S, McLean L (2004) Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis. Ann Rheum Dis 63:1166–1168
Barkhuizen A, Bennett RM (1999) Elevated levels of hyaluronic acid in the sera of women with fibromyalgia. J Rheumatol 26:2063–2064
Wigley RD, Page B, Chambers EM (2001) Hyaluronic acid serum levels in fibromyalgia, nonspecific arm disorder, and controls. J Rheumatol 28:2563
Lindqvist U, Chichibu K, Delpech B, Goldberg RL, Knudson W, Poole AR et al (1992) Seven different assays of hyaluronan compared for clinical utility. Clin Chem 38:127–132
Engstrom-Laurent A, Laurent UB, Lilja K, Laurent TC (1985) Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 45:497–504
Lindqvist U, Laurent TC (1992) Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 52:613–621
Engstrom-Laurent A, Hallgren R (1987) Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum 30:1333–1338
Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M (1999) Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 42:2561–2568
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, JS., Lee, SS., Kim, TJ. et al. Serum hyaluronic acid levels do not explain morning stiffness in patients with fibromyalgia. Clin Rheumatol 29, 535–539 (2010). https://doi.org/10.1007/s10067-010-1372-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1372-z